Activation of PPARdelta alters lipid metabolism in db/db mice. (Q54050945)

24 May 2018

title

Activation of PPARdelta alters lipid metabolism in db/db mice. (English)

1 reference

24 May 2018

author

Helene Duez

5

1 reference

24 May 2018

Johan Auwerx

16

object named as

Auwerx J

1 reference

24 May 2018

Leibowitz MD

1

1 reference

24 May 2018

Fiévet C

2

1 reference

24 May 2018

Hennuyer N

3

1 reference

24 May 2018

Peinado-Onsurbe J

4

1 reference

24 May 2018

Bergera J

6

1 reference

24 May 2018

Cullinan CA

7

1 reference

24 May 2018

Sparrow CP

8

1 reference

24 May 2018

Baffic J

9

1 reference

24 May 2018

Berger GD

10

1 reference

24 May 2018

Santini C

11

1 reference

24 May 2018

Marquis RW

12

1 reference

24 May 2018

Tolman RL

13

1 reference

24 May 2018

Smith RG

14

1 reference

24 May 2018

Moller DE

15

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

24 May 2018

published in

FEBS Letters

1 reference

24 May 2018

volume

473

1 reference

24 May 2018

issue

3

1 reference

24 May 2018

page(s)

333-336

1 reference

24 May 2018

Peroxisome proliterator-activated receptors, orphans with ligands and functions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

The molecular genetics of rodent single gene obesities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

Peroxisome proliferator-activated receptor gamma and the control of adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901554-4

10.1016/S0014-5793(00)01554-4

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10818235

1 reference

24 May 2018